Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195881 · ClinicalTrials.gov registry record
Neuroprognostication Using Optic Nerve Sheath Diameter
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 25
- Enrollment target
NCT03195881: Completed study, sponsored by TriHealth.
NCT03195881 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03195881 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study investigates the relationship between optic nerve sheath diameter and increased intracranial pressure and its effect on neurologic outcome in post-cardiopulmonary arrest patients.
Primary Outcome
Optic nerve sheath diameter within 6 hours of hypothermic protocol initiation
Interventions
- OTHER Ocular ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2019-12-09 |
What the finished NCT03195881 record still lists
NCT03195881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ocular ultrasound is the first listed.
NCT03195881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03195881 about?
NCT03195881 is a clinical study titled "Neuroprognostication Using Optic Nerve Sheath Diameter". This study investigates the relationship between optic nerve sheath diameter and increased intracranial pressure and its effect on neurologic outcome in post-cardiopulmonary arrest patients.
What is the current status of trial NCT03195881?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-05-02. Estimated completion is 2019-12-09.
What interventions are being tested in trial NCT03195881?
The interventions under investigation include: Ocular ultrasound (OTHER).
Who is sponsoring clinical trial NCT03195881?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI